This app simplifies biotech stock analysis by consolidating crucial data like clinical trials, FDA decisions, and analyst ratings. It offers tools to research, track, and understand complex biotech information through clear insights and actionable data.
2.5
July 16, 2026
- Fixed: search suggestions were cut off after a couple of rows; the results list now expands to show up to half the screen
Biostock provides real-time stock prices and market data, analyst ratings, price targets, and AI-analyzed SEC filings with sentiment scoring. It focuses on biotech-specific information like clinical trial updates and FDA decisions.
Biostock features a catalyst calendar that includes FDA, clinical, and earnings events, allowing users to monitor upcoming catalysts. Custom watchlists also offer a calendar view to ensure no important events are missed.
Yes, Biostock is designed to make biotech investing accessible. It translates complex data into clear, actionable insights with plain-language summaries and color-coded ratings to help new investors understand the market.
Biostock includes 'Signal Picks,' a daily trading strategy that comes with backtested results. This feature aims to provide users with a data-driven approach to their trading decisions.
While specific security measures are not detailed, the app focuses on providing reliable financial data. As a finance app, it is expected to adhere to industry standards for data protection and user privacy.
The latest version of Biostock is 2.4, and it was last updated on June 7, 2026. This indicates a recent update, suggesting ongoing development and maintenance.
Biostock is currently supported on iPhones. Information regarding Android or other platform availability is not provided in the current data.
No, Biostock does not contain advertisements. The app is free to download and use without any ad interruptions.
